Cargando…

Viral Rebound Kinetics Correlate with Distinct HIV Antibody Features

Plasma viremia reoccurs in most HIV-infected individuals once antiretroviral therapy (ART) is interrupted. The kinetics of viral rebound, specifically the time until plasma virus becomes detectable, differ quite substantially between individuals, and associations with virological and immunological f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartsch, Yannic C., Loos, Carolin, Rossignol, Evan, Fajnzylber, Jesse M., Yuan, Dansu, Avihingsanon, Anchalee, Ubolyam, Sasiwimol, Jupimai, Thidarat, Hirschel, Bernard, Ananworanich, Jintanat, Lauffenburger, Douglas A., Li, Jonathan Z., Alter, Galit, Julg, Boris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092214/ https://www.ncbi.nlm.nih.gov/pubmed/33688003 http://dx.doi.org/10.1128/mBio.00170-21

Ejemplares similares

Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count <200 cells/mm(3) in Thailand()
por: Han, Win Min, et al.
Publicado: (2020)

Low-level genital HIV shedding in Thai HIV-infected women with suppressed plasma viral load after menopause: a longitudinal study
por: Landolt, Nadia Kancheva, et al.
Publicado: (2017)

Restoration of CMV-Specific-CD4 T Cells with ART Occurs Early and Is Greater in Those with More Advanced Immunodeficiency
por: Hsu, Denise C., et al.
Publicado: (2013)

Functional Compartmentalization of Antibodies in the Central Nervous System During Chronic HIV Infection
por: Spatola, Marianna, et al.
Publicado: (2022)

Supersensitive Viral Load Assay in Predicting CD4-Guided Treatment Failure
por: Langford, Simone, et al.
Publicado: (2008)

Incidence and factors associated with active tuberculosis among people living with HIV after long-term antiretroviral therapy in Thailand: a competing risk model
por: Gatechompol, Sivaporn, et al.
Publicado: (2022)

Risk factors of chronic hepatitis in antiretroviral-treated HIV infection, without hepatitis B or C viral infection
por: Chalermchai, Thep, et al.
Publicado: (2013)

Prevalence of latent tuberculosis infection and feasibility of TB preventive therapy among Thai prisoners: a cross-sectional study
por: Gatechompol, Sivaporn, et al.
Publicado: (2021)

Carbohydrate, lipid, bone and inflammatory markers in HIV-positive adolescents on antiretroviral therapy and hormonal contraception
por: Kancheva Landolt, Nadia, et al.
Publicado: (2017)

Treatment outcomes and factors associated with mortality among individuals with both TB and HIV in the antiretroviral era in Thailand
por: Gatechompol, Sivaporn, et al.
Publicado: (2019)

Association of Phenotypic Aging Marker with comorbidities, frailty and inflammatory markers in people living with HIV
por: Han, Win Min, et al.
Publicado: (2022)

Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection
por: Colby, Donn, et al.
Publicado: (2018)

Evolution of functional antibodies following acute Epstein-Barr virus infection
por: Karsten, Christina B., et al.
Publicado: (2022)

A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection
por: Ananworanich, Jintanat, et al.
Publicado: (2008)

Decision making for invasive and non-invasive optional procedures within an acute HIV research cohort in Bangkok
por: Isaacson, Sinéad, et al.
Publicado: (2022)

Corrigendum to ‘Decision making for invasive and non-invasive optional procedures within an acute HIV research cohort in Bangkok,’ [Contemporary Clinical Trials Communication (2023)101054]
por: Isaacson, Sinéad, et al.
Publicado: (2023)

Adherence and Risk Behaviour in Patients with HIV Infection Receiving Antiretroviral Therapy in Bangkok
por: Clarke, Amanda, et al.
Publicado: (2012)

Going off antiretroviral treatment in a closely monitored HIV “cure” trial: longitudinal assessments of acutely diagnosed trial participants and decliners
por: Henderson, Gail E, et al.
Publicado: (2019)

Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment
por: Henderson, Gail E, et al.
Publicado: (2018)

Correlation of Selenium and Zinc Levels to Antiretroviral Treatment Outcomes in Thai HIV-infected Children without Severe HIV Symptoms
por: Bunupuradah, Torsak, et al.
Publicado: (2012)

Functional Antibodies in COVID-19 Convalescent Plasma
por: Herman, Jonathan D., et al.
Publicado: (2021)

Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response
por: Herman, Jonathan D., et al.
Publicado: (2021)

Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine
por: Bartsch, Yannic C., et al.
Publicado: (2023)

Distinct clonal evolution of B-cells in HIV controllers with neutralizing antibody breadth
por: Cizmeci, Deniz, et al.
Publicado: (2021)

Viral Blips After Treatment Initiation During Acute Human Immunodeficiency Virus Infection
por: Crowell, Trevor A, et al.
Publicado: (2020)

Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity
por: Loos, Carolin, et al.
Publicado: (2020)

To rebound or not to rebound
por: Stahl, Bethany A, et al.
Publicado: (2017)

Determinants of suboptimal CD4(+) T cell recovery after antiretroviral therapy initiation in a prospective cohort of acute HIV‐1 infection
por: Handoko, Ryan, et al.
Publicado: (2020)

Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cells
por: Rossignol, Evan D., et al.
Publicado: (2021)

An Integrated Approach to HIV Disclosure for HIV-Affected Families in Thailand
por: Jantarapakde, Jureeporn, et al.
Publicado: (2019)

Generic and low dose antiretroviral therapy in adults and children: implication for scaling up treatment in resource limited settings
por: Ramautarsing, Reshmie, et al.
Publicado: (2010)

HIV cure research: a formidable challenge
por: Ananworanich, Jintanat, et al.
Publicado: (2015)

Preserved recognition of Omicron spike following COVID-19 messenger RNA vaccination in pregnancy
por: Bartsch, Yannic C., et al.
Publicado: (2022)

Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection
por: Ananworanich, Jintanat, et al.
Publicado: (2016)

HIV-associated cognitive performance and psychomotor impairment in a Thai cohort on long-term cART
por: Do, Tanya C, et al.
Publicado: (2018)

Preclinical Immunogenicity and Efficacy of a Multiple Antigen-Presenting System (MAPS(TM)) SARS-CoV-2 Vaccine
por: Cieslewicz, Brian, et al.
Publicado: (2022)

How Much HIV is Alive? The Challenge of Measuring Replication Competent HIV for HIV Cure Research
por: Ananworanich, Jintanat, et al.
Publicado: (2015)

The transient HIV remission in the Mississippi baby: why is this good news?
por: Ananworanich, Jintanat, et al.
Publicado: (2014)

Lessons from acute HIV infection
por: Robb, Merlin L., et al.
Publicado: (2016)

Bringing Preventive RSV Monoclonal Antibodies to Infants in Low- and Middle-Income Countries: Challenges and Opportunities
por: Ananworanich, Jintanat, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_49tc8kmf4nq3nis3iajs18usfn